These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28844436)

  • 1. Psychosis subgroups differ in intrinsic neural activity but not task-specific processing.
    Hudgens-Haney ME; Ethridge LE; McDowell JE; Keedy SK; Pearlson GD; Tamminga CA; Keshavan MS; Sweeney JA; Clementz BA
    Schizophr Res; 2018 May; 195():222-230. PubMed ID: 28844436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic neural activity differences among psychotic illnesses.
    Hudgens-Haney ME; Ethridge LE; Knight JB; McDowell JE; Keedy SK; Pearlson GD; Tamminga CA; Keshavan MS; Sweeney JA; Clementz BA
    Psychophysiology; 2017 Aug; 54(8):1223-1238. PubMed ID: 28419491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium.
    Clementz BA; Parker DA; Trotti RL; McDowell JE; Keedy SK; Keshavan MS; Pearlson GD; Gershon ES; Ivleva EI; Huang LY; Hill SK; Sweeney JA; Thomas O; Hudgens-Haney M; Gibbons RD; Tamminga CA
    Schizophr Bull; 2022 Jan; 48(1):56-68. PubMed ID: 34409449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Diagnosis and Biotype Comparison Across the Psychosis Spectrum: Investigating Volume and Shape Amygdala-Hippocampal Differences from the B-SNIP Study.
    Guimond S; Gu F; Shannon H; Kelly S; Mike L; Devenyi GA; Chakravarty MM; Sweeney JA; Pearlson G; Clementz BA; Tamminga C; Keshavan M
    Schizophr Bull; 2021 Oct; 47(6):1706-1717. PubMed ID: 34254147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.
    Clementz BA; Sweeney JA; Hamm JP; Ivleva EI; Ethridge LE; Pearlson GD; Keshavan MS; Tamminga CA
    Am J Psychiatry; 2016 Apr; 173(4):373-84. PubMed ID: 26651391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced task-evoked pupillary response in preparation for an executive cognitive control response among individuals across the psychosis spectrum.
    Karpouzian-Rogers T; Sweeney JA; Rubin LH; McDowell J; Clementz BA; Gershon E; Keshavan MS; Pearlson GD; Tamminga CA; Reilly JL
    Schizophr Res; 2022 Oct; 248():79-88. PubMed ID: 35963057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic neural activity differences in psychosis biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium.
    Thomas O; Parker D; Trotti R; McDowell J; Gershon E; Sweeney J; Keshavan MS; Keedy SK; Ivleva E; Tamminga CA; Pearlson GD; Clementz BA
    Biomark Neuropsychiatry; 2019 Dec; 1():. PubMed ID: 36643612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An incongruent reality: the N400 in relation to psychosis and recovery.
    Jackson F; Foti D; Kotov R; Perlman G; Mathalon DH; Proudfit GH
    Schizophr Res; 2014 Dec; 160(1-3):208-15. PubMed ID: 25449716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditory steady-state EEG response across the schizo-bipolar spectrum.
    Parker DA; Hamm JP; McDowell JE; Keedy SK; Gershon ES; Ivleva EI; Pearlson GD; Keshavan MS; Tamminga CA; Sweeney JA; Clementz BA
    Schizophr Res; 2019 Jul; 209():218-226. PubMed ID: 31080153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An MEG study of alpha modulation in patients with schizophrenia and in subjects at high risk of developing psychosis.
    Koh Y; Shin KS; Kim JS; Choi JS; Kang DH; Jang JH; Cho KH; O'Donnell BF; Chung CK; Kwon JS
    Schizophr Res; 2011 Mar; 126(1-3):36-42. PubMed ID: 21036541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisaccade task performance in patients at ultra high risk for developing psychosis.
    Nieman D; Becker H; van de Fliert R; Plat N; Bour L; Koelman H; Klaassen M; Dingemans P; Niessen M; Linszen D
    Schizophr Res; 2007 Sep; 95(1-3):54-60. PubMed ID: 17656071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisaccade and prosaccade eye movements in individuals clinically at risk for psychosis: comparison with first-episode schizophrenia and prediction of conversion.
    Kleineidam L; Frommann I; Ruhrmann S; Klosterkötter J; Brockhaus-Dumke A; Wölwer W; Gaebel W; Maier W; Wagner M; Ettinger U
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):921-930. PubMed ID: 30635714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches.
    Ji L; Meda SA; Tamminga CA; Clementz BA; Keshavan MS; Sweeney JA; Gershon ES; Pearlson GD
    Schizophr Res; 2020 Jan; 215():430-438. PubMed ID: 31439419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression.
    Harris MS; Reilly JL; Thase ME; Keshavan MS; Sweeney JA
    Psychiatry Res; 2009 Dec; 170(2-3):150-6. PubMed ID: 19906441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emotional scene processing in biotypes of psychosis.
    Trotti RL; Parker DA; Sabatinelli D; Keshavan MS; Keedy SK; Gershon ES; Pearlson GD; Hill SK; Tamminga CA; McDowell JE; Clementz BA
    Psychiatry Res; 2023 Jun; 324():115227. PubMed ID: 37121219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saccadic eye movements in different dimensions of schizophrenia and in clinical high-risk state for psychosis.
    Obyedkov I; Skuhareuskaya M; Skugarevsky O; Obyedkov V; Buslauski P; Skuhareuskaya T; Waszkiewicz N
    BMC Psychiatry; 2019 Apr; 19(1):110. PubMed ID: 30961571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
    Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
    Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis.
    MacDonald AW; Carter CS; Kerns JG; Ursu S; Barch DM; Holmes AJ; Stenger VA; Cohen JD
    Am J Psychiatry; 2005 Mar; 162(3):475-84. PubMed ID: 15741464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications.
    Martínez A; Gaspar PA; Hillyard SA; Andersen SK; Lopez-Calderon J; Corcoran CM; Javitt DC
    Am J Psychiatry; 2018 Dec; 175(12):1243-1254. PubMed ID: 30278791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis.
    Olincy A; Martin L
    Am J Psychiatry; 2005 Jan; 162(1):43-9. PubMed ID: 15625200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.